STACEY GROSS: Open Payments
NPI 1760720221 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,154 in 35 payments from 12 companies in 2025. Trend: 2023 $1,699 · 2024 $467 · 2025 $8,154
Consulting: $3,375Travel & lodging: $2,186Honoraria: $1,500Food & beverage: $1,093
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 9 | $4,843 |
| Impulse Dynamics (USA) Inc. | 6 | $2,375 |
| Medtronic, Inc. | 4 | $222 |
| BridgeBio Pharma, Inc. | 2 | $197 |
| Novartis Pharmaceuticals Corporation | 5 | $173 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $145 |
| PFIZER INC. | 2 | $69 |
| HEARTFLOW, INC. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| SCPHARMACEUTICALS INC. | 1 | $23 |
Products named: Barostim Neo System, Optimizer, Attruby, LEQVIO, AFFERA MAPPING SYSTEM, Kerendia, ENDURANT IIS, ELIQUIS.
Industry payments across CA — which companies pay providers there.
